We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Research Backs Mammography Screening at 40

By HospiMedica International staff writers
Posted on 15 Dec 2011
Women in their 40s with no family history of breast cancer are just as prone to develop invasive breast cancer, as are women with a family history of the disease, according to a recent research. More...
These results indicate that women in this age group would benefit from yearly mammography screening.

The study’s findings were presented November 29, 2011, at the annual meeting of the Radiological Society of North America (RSNA), held in Chicago (IL, USA). The breast cancer screening guidelines issued by the US Preventive Services Task Force in November 2009 triggered a debate among physicians, patient advocacy groups, and the media. Much of the controversy focused on the recommendation against routine annual mammography screening for women in their 40s.

“We believe this study demonstrates the importance of mammography screening for women in this age group, which is in opposition to the recommendations issued by the task force,” said Stamatia V. Destounis, MD, radiologist and managing partner of Elizabeth Wende Breast Care, LLC (Rochester, NY, USA).

For the study, Dr. Destounis and colleagues performed a retrospective review to identify the number and type of cancers diagnosed among women between the ages of 40 and 49--with and without a family history of breast cancer--who underwent screening mammography at Elizabeth Wende Breast Care from 2000 to 2010. The researchers then compared the number of cancers, incidence of invasive disease and lymph node metastases between the two groups.

Of the 1,071 patients in the 40-49 age group with breast cancer, 373 were diagnosed as a result of screening. Of that 373, 39% had a family history of breast cancer, and 61% had no family history of breast cancer. In the family history group, 63.2% of the patients had invasive disease, and 36.8% had noninvasive disease. In the no family history group, 64% of the patients had invasive disease, and 36% had noninvasive disease. The respective lymph node metastatic rates were 31% and 29%.

“In the 40-49 age group, we found a significant rate of breast cancer and similar rates of invasive disease in women with and without family history,” Dr. Destounis said. “Additionally, we found the lymph node metastatic rate was similar.”

According to Dr. Destounis, these findings highlight the importance of early detection and annual screening mammography for women between the ages of 40 and 49 whether or not they have a family history of breast cancer.

Related Links:
Elizabeth Wende Breast Care



Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Multi-Chamber Washer-Disinfector
WD 390
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image: Tubes attached to this artificial lung are connected to the patient\'s neck or chest, allowing blood to circulate and get oxygen while the patient is conscious. (Image Credit: Carnegie MellonImage: Tubes attached to this artificial lung are connected to the patient\'s neck or chest, allowing blood to circulate and get oxygen while the patient is conscious. (Image Credit: Carnegie Mellon University)University)

Portable Artificial Lung Technology Could Reshape Care for Chronic Lung Disease

Chronic lung disease can leave patients dependent on prolonged mechanical ventilation or awaiting transplantation, both of which carry substantial morbidity and healthcare costs. Ventilatory support may... Read more

Surgical Techniques

view channel
Image: The thin foetoscope is guided through the abdominal wall to the placenta. Small magnets in its tip react to an externally generated magnetic field, enabling the instrument to be bent with precision. The robotic platform is designed to occlude shared blood vessels in the placenta of twins with twin-to-twin transfusion syndrome. (Image Credit: created with BioRender.com, ETH Zurich)

Robotic Platform Advances Fetoscopic Treatment of Twin-to-Twin Transfusion Syndrome

Twin-to-twin transfusion syndrome is a life-threatening complication in monochorionic twin pregnancies caused by unbalanced placental blood flow. Definitive treatment requires endoscopic laser coagulation... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.